A Bioinformatics Analysis Identifies the Telomerase Inhibitor MST-312 for Treating High-STMN1-Expressing Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is a relatively chemo-resistant tumor. Several multi-kinase inhibitors have been approved for treating advanced HCC. However, most HCC patients are highly refractory to these drugs. Therefore, the development of more effective therapies for advanced HCC patients is urg...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Szu-Jen, Yang, Pei-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145764/
https://www.ncbi.nlm.nih.gov/pubmed/33922244
http://dx.doi.org/10.3390/jpm11050332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145764/
https://www.ncbi.nlm.nih.gov/pubmed/33922244
http://dx.doi.org/10.3390/jpm11050332

Ejemplares similares